Acupuncture to Prevent Postoperative Bowel Paralysis (Paralytic Ileus)

This study has suspended participant recruitment.
Sponsor:
Information provided by:
National Center for Complementary and Alternative Medicine (NCCAM)
ClinicalTrials.gov Identifier:
NCT00065234
First received: July 18, 2003
Last updated: August 16, 2006
Last verified: August 2006
  Purpose

The purpose of this study is to determine if acupuncture is effective in preventing prolonged postoperative paralysis of the gastrointestinal tract among patients undergoing colostomy/ileostomy closure.


Condition Intervention Phase
Ileus
Neoplasms
Procedure: Acupuncture
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Prevention
Official Title: Acupuncture to Prevent Postoperative Paralytic Ileus

Resource links provided by NLM:


Further study details as provided by National Center for Complementary and Alternative Medicine (NCCAM):

Estimated Enrollment: 100
Study Start Date: September 2003
Estimated Study Completion Date: May 2006
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Previous surgical cancer treatment with ileostomy/colostomy, now scheduled for closure
  • Hospital admission must be same day as surgery

Exclusion Criteria:

  • Incapacitating disease
  • Concurrent herbal or laxative use
  • Use of Heparin or Coumadin
  • Upper or lower extremity deformities
  • Chronic constipation prior to cancer diagnosis
  • History of cerebrovascular accident or spinal cord injury
  • Chronic pain that has been treated with any form of major opioid or weak opioids (=/> 30mg/24 hours)
  • Pacemaker or metal implants
  • Concurrent alternative medicine/herbal use
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00065234

Locations
United States, Texas
MD Anderson Cancer Center
Houston, Texas, United States, 77030
Sponsors and Collaborators
Investigators
Principal Investigator: Joseph S Chiang, MD M.D. Anderson Cancer Center
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00065234     History of Changes
Other Study ID Numbers: R21 AT001065-01A1, ChiangJ
Study First Received: July 18, 2003
Last Updated: August 16, 2006
Health Authority: United States: Federal Government

Keywords provided by National Center for Complementary and Alternative Medicine (NCCAM):
Colostomy
Ileostomy

Additional relevant MeSH terms:
Ileus
Digestive System Diseases
Gastrointestinal Diseases
Intestinal Diseases
Intestinal Obstruction

ClinicalTrials.gov processed this record on October 20, 2014